Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
TSX:PRN
Total Valuation
Profound Medical has a market cap or net worth of C$186.03M. The enterprise value is C$201.97M.
Market CapC$186.03M
Enterprise ValueC$201.97M
Share Statistics
Profound Medical has 30,053,143 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,053,143
Owned by Insiders14.41%
Owned by Institutions32.15%
Financial Efficiency
Profound Medical’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -50.35%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.40
Return on Invested Capital (ROIC)-50.35%
Return on Capital Employed (ROCE)-0.52
Revenue Per Employee75.21K
Profits Per Employee-195.89K
Employee Count142
Asset Turnover0.15
Inventory Turnover0.63
Valuation Ratios
The current PE Ratio of Profound Medical is ―. Profound Medical’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value3.08
Price to FCF―
Price to Operating Cash Flow-3.96
PEG Ratio―
Income Statement
In the last 12 months, Profound Medical had revenue of 10.68M and earned -27.82M in profits. Earnings per share was -1.54.
Revenue10.68M
Gross Profit7.04M
Operating Income-33.06M
Pretax Income-27.82M
Net Income-27.82M
EBITDA-32.13M
Earnings Per Share (EPS)-1.54
Cash Flow
In the last 12 months, operating cash flow was -34.03M and capital expenditures 0.00, giving a free cash flow of -34.03M billion.
Operating Cash Flow-34.03M
Free Cash Flow-34.03M
Free Cash Flow per Share-1.13
Dividends & Yields
Profound Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-45.87%
50-Day Moving Average7.46
200-Day Moving Average8.65
Relative Strength Index (RSI)29.94
Average Volume (3m)10.51K
Important Dates
Profound Medical upcoming earnings date is Oct 30, 2025, After Close (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend Date―
Financial Position
Profound Medical as a current ratio of 10.52, with Debt / Equity ratio of 12.26%
Current Ratio10.52
Quick Ratio9.64
Debt to Market Cap0.03
Net Debt to EBITDA1.55
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Profound Medical has paid -2.00K in taxes.
Income Tax-2.00K
Effective Tax Rate<0.01
Enterprise Valuation
Profound Medical EV to EBITDA ratio is -4.24, with an EV/FCF ratio of -5.80.
EV to Sales12.74
EV to EBITDA-4.24
EV to Free Cash Flow-5.80
EV to Operating Cash Flow-5.80
Balance Sheet
Profound Medical has C$35.20M in cash and marketable securities with C$4.81M in debt, giving a net cash position of -C$30.38M billion.
Cash & Marketable SecuritiesC$35.20M
Total DebtC$4.81M
Net Cash-C$30.38M
Net Cash Per Share-C$1.01
Tangible Book Value Per ShareC$2.43
Margins
Gross margin is 68.62%, with operating margin of -309.57%, and net profit margin of -260.45%.
Gross Margin68.62%
Operating Margin-309.57%
Pretax Margin-260.47%
Net Profit Margin-260.45%
EBITDA Margin-300.81%
EBIT Margin-309.57%
Analyst Forecast
The average price target for Profound Medical is C$15.19, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$15.19
Price Target Upside151.91% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast64.42%
EPS Growth Forecast-21.09%